Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating elinzanetant versus placebo for vasomotor symptoms caused by adjuvant endocrine therapy in women with, or at high risk for, ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Elinzanetant (elinzanetant)

Snippet

Sponsor: Bayer | Conditions: Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-29